 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 2 | 1/1 | 返回列表 |
| 查看: 304 | 回復(fù): 1 | |||
zlwcw木蟲 (著名寫手)
|
[交流]
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies 已有1人參與
|
|
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies SHANGHAI, October 24, 2011 /PRNewswire via COMTEX/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of MedKey Med-Tech Development Co. Ltd. and Jiecheng Med-Tech Development Co. Ltd., two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed. Founded in 2006, MedKey/Jiecheng have about 80 employees and operate in 15 cities in China, with offices in Shanghai, Beijing, and Guangzhou. The companies provide services in regulatory affairs, Phase I-IV clinical trial management, and clinical trial site management throughout most of the regions in China. Their customer base includes both multinational pharmaceutical companies and domestic Chinese pharmaceutical companies. David Xi, founder, owner, and CEO of the companies, will continue to manage MedKey/Jiecheng as WuXi’s Executive Director of Clinical Operations. As part of WuXi, MedKey/Jiecheng will leverage WuXi’s broad customer base and will focus on clinical services needed by customers for Chinese regulatory filings and market access. “WuXi’s acquisition of Medkey/Jiecheng continues our strategy to build an integrated platform of R&D services that will allow anyone and any company to discover and develop drugs more efficiently and cost effectively for patients,” said Dr. Ge Li, Chairman and CEO of WuXi. “This acquisition provides WuXi an existing clinical development service capability and infrastructure that WuXi will expand and strengthen to serve our customers’ growing clinical development needs in the fast-growing Chinese healthcare market.” |
回復(fù)此樓» 猜你喜歡
中藥材標(biāo)準(zhǔn)目錄大全llp2026（含各省市中藥材和炮制規(guī)范）
已經(jīng)有2人回復(fù)
-
酰胺脫乙�；�
已經(jīng)有13人回復(fù)
-
藥物學(xué)論文潤色/翻譯怎么收費?
已經(jīng)有184人回復(fù)
-
見刊快的中文核心期刊
已經(jīng)有2人回復(fù)
-
一志愿天中醫(yī)中藥學(xué)專碩，希望有b區(qū)的老師可以考慮一下我
已經(jīng)有1人回復(fù)
-
調(diào)劑
已經(jīng)有3人回復(fù)
-
藥學(xué)學(xué)碩326求調(diào)劑
已經(jīng)有0人回復(fù)
-
26年博士申請
已經(jīng)有20人回復(fù)
-
求助 苯磷硫胺JP
已經(jīng)有0人回復(fù)
-
100金幣 阿莫西林克拉維酸鉀片BP藥典中提到的克拉維酸聚合物具體結(jié)構(gòu)式是啥？
已經(jīng)有2人回復(fù)
-
膳食補充劑合規(guī)性交流
已經(jīng)有0人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
lk590
木蟲 (著名寫手)
- 應(yīng)助: 24 (小學(xué)生)
- 貴賓: 0.452
- 金幣: 1667.4
- 散金: 801
- 紅花: 18
- 沙發(fā): 2
- 帖子: 1376
- 在線: 272.3小時
- 蟲號: 579330
- 注冊: 2008-07-04
- 性別: GG
- 專業(yè): 臨床藥理
2樓2011-10-25 10:47:28
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 zlwcw 的主題更新
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 307求調(diào)劑 +3 | wyyyqx 2026-03-17 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 材料工程（專）一志愿985 初試335求調(diào)劑 +3 | hiloiy 2026-03-17 | 4/200 |
|
|
|
[考研]
 271材料工程求調(diào)劑
+8
|
.6lL 2026-03-18 | 8/400 |
|
|
|
[考研] 294求調(diào)劑材料與化工專碩 +15 | 陌の森林 2026-03-18 | 15/750 |
|
|
|
[考研] 317求調(diào)劑 +5 | 申子申申 2026-03-19 | 9/450 |
|
|
|
[考研] 一志愿 西北大學(xué) ，070300化學(xué)學(xué)碩，總分287，雙非一本，求調(diào)劑。 +4 | 晨昏線與星海 2026-03-19 | 4/200 |
|
|
|
[考研] 中南大學(xué)化學(xué)學(xué)碩337求調(diào)劑 +3 | niko- 2026-03-19 | 6/300 |
|
|
|
[考研] 一志愿西南交通 專碩 材料355 本科雙非 求調(diào)劑 +5 | 西南交通專材355 2026-03-19 | 5/250 |
|
|
|
[考研] 265求調(diào)劑 +12 | 梁梁校校 2026-03-19 | 13/650 |
|
|
|
[考研] 一志愿北京化工大學(xué)0703化學(xué)318分，有科研經(jīng)歷，求調(diào)劑 +4 | 一瓶苯甲酸 2026-03-14 | 4/200 |
|
|
|
[考研] 0856調(diào)劑，是學(xué)校就去 +8 | sllhht 2026-03-19 | 9/450 |
|
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
|
[考研] 085600材料與化工調(diào)劑 324分 +10 | llllkkkhh 2026-03-18 | 12/600 |
|
|
|
[考研] 304求調(diào)劑 +12 | 小熊joy 2026-03-14 | 13/650 |
|
|
|
[考研] 268求調(diào)劑 +8 | 一定有學(xué)上- 2026-03-14 | 9/450 |
|
|
|
[考研] 290求調(diào)劑 +3 | p asserby. 2026-03-15 | 4/200 |
|
|
|
[考研] 有沒有道鐵/土木的想調(diào)劑南林，給自己招師弟中～ +3 | TqlXswl 2026-03-16 | 7/350 |
|
|
|
[考研] 材料工程專碩274一志愿211求調(diào)劑 +6 | 薛云鵬 2026-03-15 | 6/300 |
|
|
|
[考研]
11408 一志愿西電，277分求調(diào)劑
+3
|
zhouzhen654 2026-03-16 | 3/150 |
|
|
|
[考研] 318求調(diào)劑 +3 | Yanyali 2026-03-15 | 3/150 |
|